China NMPA Drug Inspection - Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. - Isosorbide dinitrate tablets
China NMPA drug inspection for Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. published October 10, 2018. Drug: Isosorbide dinitrate tablets. This document, the "Ningxia Drug Sampling Inspection Information Announcement (No. 11, 2018)," was issued by the Ningxia
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Shanghai Fudan Fuhua Pharmaceutical Co., Ltd. published October 10, 2018. Drug: Isosorbide dinitrate tablets. This document, the "Ningxia Drug Sampling Inspection Information Announcement (No. 11, 2018)," was issued by the Ningxia
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox